The idea for the RxStudy Card was born when a clinical supply by one of the top five global pharmaceutical sponsors was in jeopardy because one vital component required five months to secure. RxSolutions was able to radically reduce the handling process, thereby establishing itself as the service of choice for top pharma and CROs in North America. We spoke to company president Tom Heck about the benefits it brings.
Tom Heck: A large pharma sponsor once said, "Inventory doesn't solve problems, it creates them." As RxSolutions has now surveyed many clinical supply managers, it understands this. When the company discovered no fewer than 16 steps in securing clinical trial supplies, managing them throughout the trial and then the destruction of leftover material, the supply process seemed like retail shopping before Amazon; inefficient in cost and human capital. RxSolutions provides a more efficient way to deliver unblinded supplies into the hands of study subjects.
Rather than procuring, labelling, numerous stages of picking, packing, shipping, then managing inventory for months or years, and finally destroying it, the RxStudy Card helps to simplify the clinical supply process. RxSolutions saves administrative time, shortens the clinical supply process timeline, adds flexibility to allow changes; minimises waste; lowers capital expense, enhances subject safety; and reduces the stress associated with the procurement and distribution process of the unblinded medication, ancillary supplies and medical devices used in studies.
The RxStudy Card saves clinical study teams significant time and hassle compared with more traditional supply processes by providing sites with approved medications and materials though an insurance-like card that enables sponsors to pharmacies as they are dispensed at pharmacies.
RxSolutions focuses on making the lives of clinical supply staff simpler by doing the majority of the work for them, and giving them a state-of-the-art web portal with which to monitor the success of the programme.
It can be used in any phase study requiring unblinded supplies to include large formularies, fast study start or start-up in the middle of study. It makes available standard of care; rescue medications; scheduled products best dispensed at pharmacies to the end subject; ancillary supplies (OTC medications, diabetes needles, asthma spacers and so on), as well as hard-to-procure medicines like biologics.
Temperature excursions can be eliminated for sensitive products by letting pharmacies manage the distribution of the unblinded clinical trial supplies the way they traditionally would. This unsaddles clients with the burden of temperature issues, placing the risk on the pharmacies, who are well suited to manage transportation matters. Avoiding these issues can reduce a lot of waste where unblinded clinical trial supplies are concerned.
The company has seen wide adoption into speciality and central pharmacies and HUB service providers. It has also provided insight-driven patient savings programmes - in the form off co-pay offsets and free trial offers - for commercialised products to drive incremental brand revenue for more than 20 years.
RxSolutions manages clients' clinical investments through all life-cycles of the product. The company is excited about the commercial and clinical offerings now being introduced to the market in smarter ways.
RxSolutions is restless when it comes to innovation, and success will come from responsive client-focused consultation from an experienced team with solid market knowledge. The company's mission is to treat its clients as it would wish to be treated - fairly, responsibly and with integrity.
While most top ten pharma have used the service, as well as their chosen CROs, the challenge lies in educating clinical supply staff that there is a much better way that can save millions of dollars in needless distributions cost and headaches. The current system is so inefficient, and RxStudy Card is so simple.
The only competitors it has are the bulk suppliers of medications that ship bulk supplies that have to be speciality packed for the clinical study.